评估改善加纳农村场外药品销售者疟疾「检测、治疗、追踪」策略的干预措施:整群随机对照试验研究方案
干预组引入补贴疟疾快速诊断检测(mRDT)并培训OTCMS,辅以督导、技术支持和反馈;主要结局为10岁以下发热或疑似疟疾儿童在治疗前接受mRDT检测的比例,次要结局包括对国家疟疾治疗指南的依从性和推荐mRDT零售价。
要点
- 干预组OTCMS接受mRDT使用培训并引入补贴检测试剂,定期督导反馈。
- 主要结局为10岁以下发热儿童就诊时治疗前接受mRDT检测的比例。
核心结论
- 该试验将评估提供者与社区干预联合改善加纳农村OTCMS对T3策略依从性的效果。
研究设计与样本
- 两臂整群随机对照试验,在加纳Fanteakwa North和South两区8个农村社区(每臂4个集群)开展。
- 干预臂纳入8名OTCMS,对照臂纳入5名OTCMS。
- 干预臂OTCMS经培训后引入补贴mRDT试剂盒,定期接受督导、技术支持、反馈和数据收集。
关键数值与推荐
- 主要结局:10岁以下发热或疑似疟疾儿童就诊OTCMS并在治疗前接受mRDT检测的比例。
- 次要结局包括对国家疟疾治疗指南的依从性和推荐mRDT零售价。
- 结局测量主要采用家庭调查,辅以神秘顾客调查和OTCMS疟疾检测监测登记簿。
临床怎么用
- 为在疟疾流行区农村场外药品销售点推广mRDT和T3策略提供可规模化干预方案的证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The World Health Organization initiated test, treat, and track (T3) malaria strategy to support malaria-endemic countries in their efforts to achieve universal coverage with diagnostic testing, antimalarial treatment, and strengthening surveillance systems. Unfortunately, T3 is not adopted by over-the-counter medicine sellers (OTCMS) where many patients with malaria-like symptoms first seek treatment. Sub-Saharan African countries are considering introducing and scaling up RDTs in these outlets to reduce malaria burden. In this context, this study is aimed at improving implementation of the T3 among OTCMS using a number of intervention tools that could be scaled-up easily at the national level. METHODS/DESIGN: The interventions will be evaluated using a two-arm, cluster randomized trial across 8 rural communities (4 clusters per arm), in two adjacent districts (Fanteakwa North and Fanteakwa South districts) of Ghana. A total of 8 OTCMS in the intervention arm and 5 OTCMS in the control arm in the selected communities will participate in the study. In the intervention arm only, subsidized malaria rapid diagnostic test (mRDT) kits will be introduced after the OTCMS have been trained on how to use the kit appropriately. Supervision, technical assistance, feedbacks, and collection of data will be provided on a regular basis at the participating medicine stores. The primary outcome is the proportion of children under 10 years with fever or suspected to have malaria visiting OTCMS and tested (using mRDT) before treatment. Secondary outcomes will include adherence to national malaria treatment guidelines and recommended mRDT retail price. Outcomes will be measured using mainly a household survey supplemented by mystery client survey and a surveillance register on malaria tests conducted by the OTCMS during patient consultations. Data collected will be double entered and verified using Microsoft Access 2010 (Microsoft Inc., Redmond, Washington) and analyzed using STATA version 11.0. DISCUSSION: The trial will provide evidence on the combined effectiveness of provider and community interventions in improving adherence to the T3 initiative among OTCMS in rural Ghana. ETHICAL CLEARANCE: NMIMR-IRB CPN 086/18-19 TRIAL REGISTRATION: ISRCTN registry ISRCTN77836926 . Registered on 4 November 2019.
引用
- Soniran OT, Abuaku B, Ahorlu CS, et al. Evaluating interventions to improve test, treat, and track (T3) malaria strategy among over-the-counter medicine sellers (OTCMS) in some rural communities of Fanteakwa North district, Ghana: study protocol for a cluster randomized controlled trial. Trials. 2020. PMID: 32641094. doi:10.1186/s13063-020-04509-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。